tiprankstipranks
Trending News
More News >
NextCell Pharma AB (DE:65G)
FRANKFURT:65G
Germany Market

NextCell Pharma AB (65G) Income Statement

Compare
0 Followers

NextCell Pharma AB Income Statement

Last quarter (Q1 2026), NextCell Pharma AB's total revenue was kr1.77M, a decrease of -37.45% from the same quarter last year. In Q1, NextCell Pharma AB's net income was kr-13.79M. See NextCell Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 25Aug 24Aug 23Aug 22Aug 21
Total Revenue
kr 10.94Mkr 10.66Mkr 10.11Mkr 5.59Mkr 3.91M
Gross Profit
kr -35.87Mkr -4.56Mkr -884.83Kkr -22.26Mkr -14.53M
Operating Expenses
kr 0.00kr 38.61Mkr 40.12Mkr 12.76Mkr 10.38M
Depreciation and Amortization
kr 2.52Mkr 974.67Kkr 447.88Kkr 457.34Kkr 437.02K
EBITDA
kr -32.63Mkr -40.99Mkr -39.36Mkr -34.10Mkr -24.21M
Operating Income
kr -35.87Mkr -43.17Mkr -41.00Mkr -35.02Mkr -24.82M
Other Income/Expenses
kr 728.70Kkr 1.21Mkr 1.19Mkr 469.57Kkr 264.27K
Pretax Income
kr -35.14Mkr -41.96Mkr -39.81Mkr -34.55Mkr -24.56M
Net Income
kr -35.14Mkr -41.96Mkr -39.81Mkr -34.08Mkr -24.56M
Per Share Metrics
Basic EPS
kr -0.46kr -0.57kr -0.58kr -0.50kr -0.40
Diluted EPS
kr -0.46kr -0.57kr -0.58kr -0.50kr -0.40
Weighted Average Shares Outstanding
76.41M 73.09M 68.76M 68.76M 60.82M
Weighted Average Shares Outstanding (Diluted)
76.41M 73.09M 68.76M 68.76M 60.82M
Currency in SEK

NextCell Pharma AB Earnings and Revenue History